ArrowPath Venture Partners
34
10M
17
6
0.50
14
- Stages of investment
- Areas of investment
Summary
The venture was found in North America in United States. The main department of described VC is located in the Redwood Shores.
The current fund was established by Thomas A. Bevilacqua.
Opposing the other organizations, this ArrowPath Venture Partners works on 12 percentage points more the average amount of lead investments. The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2008. Speaking about the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2007. The common things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the ArrowPath Venture Partners, startups are often financed by DFJ, El Dorado Ventures, U.S. Venture Partners (USVP). The meaningful sponsors for the fund in investment in the same round are DFJ, El Dorado Ventures, Trident Capital. In the next rounds fund is usually obtained by El Dorado Ventures, DFJ, Cardinal Venture Capital.
Among the various public portfolio startups of the fund, we may underline Everypath, Harris ERP, Gamma Enterprise Technologies Among the most successful fund investment fields, there are Telecommunications, Enterprise Software. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Investments analytics
Analytics
- Total investments
- 34
- Lead investments
- 6
- Exits
- 14
- Follow on index
- 0.50
- Investments by industry
- Enterprise Software (16)
- Software (14)
- Security (11)
- Network Security (8)
- Web Hosting (6) Show 22 more
- Investments by region
- United States (34)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 41M
- Group Appearance index
- 0.94
- Avg. company exit year
- 12
- Avg. multiplicator
- 1.37
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| BinOptics | 10 Feb 2005 | Manufacturing, Product Design, Telecommunications | Early Stage Venture | 10M | United States, New York, Ithaca |
| Metro Africa Express | 29 Mar 2016 | Logistics, Supply Chain Management, Transportation, Delivery | Seed | 1M | Lagos, Lagos, Nigeria |
| Memed | 20 Feb 2014 | Information Technology, Health Care, Medical | Early Stage Venture | 1M | Brazil, São Paulo |
| Sanera Systems | 03 Jul 2003 | Enterprise Software, Hardware, Web Hosting | Late Stage Venture | 35M | United States, California, San Jose |
| True North Therapeutics | 17 Jun 2014 | Biotechnology, Health Care, Clinical Trials | Early Stage Venture | 22M | United States, California, South San Francisco |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.